The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials

BACKGROUND: Abiraterone acetate, a CYP17 enzyme inhibitor, can block the synthesis of androgens in the adrenal gland, prostate, and testis. The purpose of this study was to investigate the efficacy and safety of abiraterone acetate in high-risk prostate cancer patients, including metastatic castrati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Androl Urol
Hlavní autoři: Tan, Guobin, Xuan, Zijun, Li, Zhiqin, Huang, Shuitong, Chen, Guangming, Wu, Yonglu, Chen, Xianxi, Liang, Zhijin, Wu, Aiming
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475664/
https://ncbi.nlm.nih.gov/pubmed/32944530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1058
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky